BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

DiscoveRx Corporation 

42501 Albrae Street

Fremont  California  94538  U.S.A.
Phone: 510-979-1415 Fax: 510-979-1650


SEARCH JOBS

DiscoveRx® is a fast growing innovative company that develops, manufactures, and commercializes reagents and complete assay kits for the drug discovery and screening markets. Our products, biochemical and cell-based assays, enable customers to improve research productivity and effectiveness, thus accelerating the discovery and development of new drugs.

Founded in 2000, DiscoveRx is a privately held, venture-backed company headquartered in California with offices in England, Germany, and France. DiscoveRx is dedicated to the development and commercialization of innovative solutions to study major drug target classes such as GPCRs and kinases.

DiscoveRx assay solutions are based on our core proprietary Enzyme Fragment Complementation (EFC) technology that is well established in clinical diagnostics and now further enhanced to provide unique solutions to drug discovery research. EFC technology is a proven, established screening technology in most major pharmaceutical companies and our EFC-based HitHunter™ cAMP assays are the market leader in GPCR screening applications. PathHunter™ technology, an adaptation of EFC technology, is an innovative and comprehensive assay system that enables in vivo cell-based assays for pathway profiling and screening. Through our core HitHunter™, PathHunter™, and EFC technologies, DiscoveRx is able to offer assay solutions for every major class of drug target, including GPCRs, kinases, proteases, nuclear hormone receptors, transcription factors, and secreted proteins.

DiscoveRx – Simple Solutions for Complex Biology

Last Updated: 03-14-2006


 Key Statistics


Email: info@discoverx.com
Ownership: Private

Web Site: DiscoveRx Corporation
Employees:
Symbol: 
 



Industry
Biotechnology






 Company News
DiscoveRx Corporation Platforms For Phenotypic And Target Based Screening Provide Unique Tools For Cancer Therapeutic Discovery 4/7/2014 10:51:46 AM    More...
DiscoveRx Corporation And Collaborators Present Data On Safety, Bioactivities Of Wide Range Of Substances To Society Of Toxicology 3/27/2014 10:38:39 AM    More...
DiscoveRx Corporation Announces Launch of New Human Primary Cell-Based Panels for Oncology Research 9/12/2013 9:47:52 AM    More...
DiscoveRx Corporation Acquires BioSeek, LLC. 11/7/2012 10:03:10 AM    More...
DiscoveRx Corporation Breaks the Barriers of Conventional Cell-Based Screening with Launch of a Powerful New InCELL Hunter™ Platform 6/5/2012 10:49:55 AM    More...
DiscoveRx Corporation Introduces a High-Throughput Biochemical Screening Platform for Bromodomain Epigenetic “Reader” Proteins 5/16/2012 10:02:12 AM    More...
DiscoveRx Corporation Release: Comprehensive PathHunter® Assay Portfolio Driving Antibody Therapeutic Discovery Programs 5/1/2012 9:13:53 AM    More...
DiscoveRx Corporation Continues to Innovate with Solutions for Epigenetic Drug Discovery Programs 2/3/2012 7:04:25 AM    More...
Compugen Ltd. (CGEN) and DiscoveRx Corporation Form Collaboration to Commercialize Novel Peptide Ligands for GPCR Drug Targets 11/29/2011 8:57:37 AM    More...
DiscoveRx Corporation Announces the Expansion of KINOMEscan’s Largest Commercially Available Kinase Panel 6/2/2011 8:37:44 AM    More...
1234

//-->